ages, licensees who can find products and delivery methods to that are desirable to patients in their later years may benefit handsomely.
Indeed, an entire part of the regulations under the Cannabis Act is devoted to regulating drugs that contain cannabis. Licensees focused on the medical market are not only more likely to engage in the research necessary to develop these types of products, but will also be better able to leverage their existing brand reputation in the medical industry to give credibility to new products that they may develop.
While the population and the media are fixated on the pending legalization of cannabis for recreational use, businesses and investors alike should pause for a moment to consider the potential that exists for companies who are willing and able to execute effectively within the medical market. Those that do may ultimately find themselves further ahead in the long term.
213